{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:55:50Z","timestamp":1788033350153,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1400,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/jto.0b013e3182398e4f","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T08:20:28Z","timestamp":1321518028000},"page":"382-385","source":"Crossref","is-referenced-by-count":235,"title":["Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Patrick G.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Rosenvald","family":"Szenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Panageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3182398e4f_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib2","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial","volume":"290","author":"Kris","year":"2003","journal-title":"JAMA"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib3","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2003.12.008","article-title":"Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer","volume":"21","author":"Miller","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1200\/JCO.2008.18.7658","article-title":"First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy","volume":"27","author":"Inoue","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib6","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cncr.21033","article-title":"High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib","volume":"103","author":"Omuro","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib9","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","article-title":"Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis","volume":"116","author":"Glantz","year":"2010","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-007-9511-3","article-title":"Continuous intrathecal treatment with methotrexate via subcutaneous port: implication for leptomeningeal dissemination of malignant tumors","volume":"87","author":"Shinoura","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib11","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1200\/JCO.2007.11.1807","article-title":"Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8","volume":"25","author":"Kramer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0929-6646(08)60201-6","article-title":"Cytologically proven meningeal carcinomatosis in patients with lung cancer: clinical observation of 34 cases","volume":"107","author":"Chuang","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lungcan.2008.11.017","article-title":"Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer","volume":"65","author":"Kim","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11060-004-8101-x","article-title":"Leptomeningeal metastases from solid malignancy: a review","volume":"75","author":"Taillibert","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02327385","article-title":"Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases\u2014a Southwest Oncology Group study","volume":"6","author":"Sause","year":"1988","journal-title":"J Neurooncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","article-title":"Ventriculoperitoneal shunt in patients with leptomeningeal metastasis","volume":"64","author":"Omuro","year":"2005","journal-title":"Neurology"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lungcan.2008.10.016","article-title":"Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI","volume":"65","author":"Yi","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/JTO.0b013e3181b62572","article-title":"Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib","volume":"4","author":"Katayama","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00280-011-1555-6","article-title":"Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy","volume":"67","author":"Masuda","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/JTO.0b013e3181757a8b","article-title":"Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma","volume":"3","author":"Wagner","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-010-0128-6","article-title":"High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer","volume":"99","author":"Clarke","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1097\/JTO.0b013e3182398e4f_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11060-010-0200-2","article-title":"Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer","volume":"100","author":"De Braganca","year":"2010","journal-title":"J Neurooncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415332421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415332421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T12:23:23Z","timestamp":1543407803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415332421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1556086415332421"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3182398e4f","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}